You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tirelizumab；Chemotherapy monotherapy
  • (no location specified)
Jul 27, 2023

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

Relapsed or Advanced NSCLC Trial (Almonertinib combined with SHR-1701, Almonertinib)

Not yet recruiting
  • Relapsed or Advanced Non-small Cell Lung Cancer
  • (no location specified)
Aug 16, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Davis, California
  • +13 more
Nov 7, 2022

Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Dec 20, 2022

Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)

Recruiting
  • Non-small-cell Lung Cancer Patients
  • Roma, RM, Italy
    Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Sep 30, 2022

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)

Recruiting
  • Melanoma
  • +2 more
  • LYL845
  • Columbus, Ohio
  • +3 more
Dec 19, 2022

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • GEN1046
  • Pembrolizumab
  • Santa Rosa, California
  • +26 more
Jan 30, 2023

Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

Not yet recruiting
  • Relapse
  • +7 more
  • Visakhapatnam, Andhra Pradesh, India
  • +5 more
May 7, 2023

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

NSCLC(NSCLC) Trial in Nanjing (BP102, paclitaxel, carboplatin, Avastin®, paclitaxel, carboplatin)

Completed
  • Non-small Cell Lung Cancer(NSCLC)
  • BP102, paclitaxel, carboplatin
  • Avastin®, paclitaxel, carboplatin
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Dec 23, 2021

Metastatic NSCLC Trial in New York (Dupilumab, PD-1/PD-L1 blockade)

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • New York, New York
    Tisch Cancer Institute, Mount Sinai Hospital
Sep 29, 2021

Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 27, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022

Relapsed or Metastatic NSCLC Trial in Guangzhou (Glumetinib combined with Toripalimab)

Recruiting
  • Relapsed or Metastatic Non-small Cell Lung Cancer
  • Glumetinib combined with Toripalimab
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Mar 10, 2021

Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

Recruiting
  • Cancer
  • +7 more
  • ST-067
  • Scottsdale, Arizona
  • +3 more
Mar 21, 2022

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023